Report for Pei H

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : PI3K-Akt signaling pathway based on network pharmacology for the anti-Alzheimer's disease effect of licorice stem flavonoids - Pei_2023_Aging.(Albany.NY)_15_
Author(s) : Pei H , He L , Shi M , Guo X , Chen W , Li J , He Z , Du R
Ref : Aging (Albany NY) , 15 : , 2023
Abstract : Pei_2023_Aging.(Albany.NY)_15_
ESTHER : Pei_2023_Aging.(Albany.NY)_15_
PubMedSearch : Pei_2023_Aging.(Albany.NY)_15_
PubMedID: 37166431

Title : Palmatine attenuates LPS-induced neuroinflammation through the PI3K\/Akt\/NF-B pathway - Zeng_2023_J.Biochem.Mol.Toxicol__e23544
Author(s) : Zeng J , Pei H , Wu H , Chen W , Du R , He Z
Ref : J Biochem Mol Toxicol , :e23544 , 2023
Abstract : Zeng_2023_J.Biochem.Mol.Toxicol__e23544
ESTHER : Zeng_2023_J.Biochem.Mol.Toxicol__e23544
PubMedSearch : Zeng_2023_J.Biochem.Mol.Toxicol__e23544
PubMedID: 37815058

Title : Plin5 Bidirectionally Regulates Lipid Metabolism in Oxidative Tissues - Zhang_2022_Oxid.Med.Cell.Longev_2022_4594956
Author(s) : Zhang X , Xu W , Xu R , Wang Z , Wang P , Peng K , Li M , Li J , Tan Y , Wang X , Pei H
Ref : Oxid Med Cell Longev , 2022 :4594956 , 2022
Abstract : Zhang_2022_Oxid.Med.Cell.Longev_2022_4594956
ESTHER : Zhang_2022_Oxid.Med.Cell.Longev_2022_4594956
PubMedSearch : Zhang_2022_Oxid.Med.Cell.Longev_2022_4594956
PubMedID: 35401929

Title : The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial - Zhang_2022_Evid.Based.Complement.Alternat.Med_2022_4778163
Author(s) : Zhang H , Chen H , Pei H , Wang H , Ma L , Li H
Ref : Evid Based Complement Alternat Med , 2022 :4778163 , 2022
Abstract : Zhang_2022_Evid.Based.Complement.Alternat.Med_2022_4778163
ESTHER : Zhang_2022_Evid.Based.Complement.Alternat.Med_2022_4778163
PubMedSearch : Zhang_2022_Evid.Based.Complement.Alternat.Med_2022_4778163
PubMedID: 35116067

Title : Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial - Liu_2020_Chin.J.Integr.Med_26_577
Author(s) : Liu NY , Pei H , Liu MX , Liu LT , Fu CG , Li H , Chen KJ
Ref : Chin J Integr Med , 26 :577 , 2020
Abstract : Liu_2020_Chin.J.Integr.Med_26_577
ESTHER : Liu_2020_Chin.J.Integr.Med_26_577
PubMedSearch : Liu_2020_Chin.J.Integr.Med_26_577
PubMedID: 32761337

Title : Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review - Wang_2020_Curr.Vasc.Pharmacol_18_358
Author(s) : Wang Z , Yang Y , Liu M , Wei Y , Liu J , Pei H , Li H
Ref : Curr Vasc Pharmacol , 18 :358 , 2020
Abstract : Wang_2020_Curr.Vasc.Pharmacol_18_358
ESTHER : Wang_2020_Curr.Vasc.Pharmacol_18_358
PubMedSearch : Wang_2020_Curr.Vasc.Pharmacol_18_358
PubMedID: 31291876

Title : Traditional Chinese Medicine Shenmayizhi Decoction Ameliorates Memory And Cognitive Impairment Induced By Scopolamine Via Preventing Hippocampal Cholinergic Dysfunction In Rats - Wu_2019_Neuropsychiatr.Dis.Treat_15_3167
Author(s) : Wu Q , Cao Y , Liu M , Liu F , Brantner AH , Yang Y , Wei Y , Zhou Y , Wang Z , Ma L , Wang F , Pei H , Li H
Ref : Neuropsychiatr Dis Treat , 15 :3167 , 2019
Abstract : Wu_2019_Neuropsychiatr.Dis.Treat_15_3167
ESTHER : Wu_2019_Neuropsychiatr.Dis.Treat_15_3167
PubMedSearch : Wu_2019_Neuropsychiatr.Dis.Treat_15_3167
PubMedID: 31814724